{{knowledge objective
|Identifiant=OIC-036-15-B
|Item_parent=Contraception. (see item 330)
|Item_parent_short=Contraception. (see item 330)
|Rank=B
|Title=Able to explain to the patient the advantages and disadvantages of the different contraceptives.
|Description=None
|Heading=Management
|Contributors=Genevi√®ve Plu-Bureau
|Order=15}}


=== '''Beneficial effects of COP''' ===
- Reduced risk of ovarian cancer (approximately 50%, time-dependent, hence COP is not contraindicated in BRCA1 or BRCA2 women)

- Reduced risk of endometrial cancer

- Reduced risk of colon cancer

- Improvement in dysmenorrhoea, functional menorrhagia and acne (whatever the type of COP).

=== '''Beneficial effects of CP''' ===
- No metabolic changes

- No change in haemostasis

- No arterial or venous vascular risk (except for injectable contraception)